A few days ago, the 14th China Bio-Industry Conference and 2022 Guanzhou International Bio-Forum opened in Huangpu District, Guangzhou and Guangzhou Development Zone. During the signing session of major bio-industry projects in this Guanzhou International Bio-Forum, Guangzhou Development Zone signed contracts with 5 companies including Fangzhou Jianke, Laien Bio and Yunzhou Bio to promote the implementation of a number of bio-pharmaceutical industry projects–
Fangzhou Jianke is the only first-tier enterprise in the “Internet + medical” industry with its headquarters in Guangdong. It will build a digital medical industry headquarters project in Guangzhou Development Zone, and build a digital medical emerging enterprise cooperation, smart chronic disease management and Internet medicine. Sales-integrated digital healthcare industry ecosystem.
LynBio, a world-leading TCR-T cell therapy company, plans to invest in the construction of a GMP cell production base in the Sino-Singapore Guangzhou Knowledge City, and serve as a headquarter of China.
The leader of gene therapy–Yunzhou Biology will build a gene delivery R&D center in Guangzhou Development Zone, and build gene therapy vector research and development for gene therapy A comprehensive platform for production and a GMP production platform for gene therapy products.
The new nano-polypeptide (protein) conjugated drug industrialization project is led by Dr. Wang Hao, and Academician Zhao Yuliang of the Chinese Academy of Sciences serves as the chief consultant. The self-developed in vivo self-assembly nanobiotechnology provides a new technical solution for the next generation of intelligent targeted diagnosis and treatment, and strives to develop new peptide-conjugated nanomedicines that have not been met by clinical needs.
“The Guanzhou International Biological Forum is a platform for the exchange and cooperation development of biotechnology and industries that can serve the whole country and even affect the world.” Ark Xie Fangmin, founder of Jianke, said, “With the help of Guanzhou International Bio Forum’s unique biotechnology industry’s ability to aggregate resources and the conditions of high-end talent gathering places, it can assist enterprises to gather innovative resources, accumulate high-quality customer groups, introduce high-end talents, attract investment, and accelerate Industrial integration.”
Lan Tian, founder and chief scientist of Yunzhou Biology, also believes that the genetic engineering industry has good development prospects in Guangzhou. After settlement, it will achieve rapid development. “The government attaches great importance to it, and the industrial agglomeration effect of the Guangdong-Hong Kong-Macao Greater Bay Area is gradually showing.”
[Source: Guangzhou Daily]
p>
Disclaimer: This article is reproduced for the purpose of conveying more information. If the source is incorrectly marked or infringes your legal rights, please contact the author with the ownership certificate, we will correct or delete it in time, thank you. Email address: [email protected]